Skip to content

Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges

Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05205434
Enrollment
57
Registered
2022-01-25
Start date
2021-09-25
Completion date
2022-09-07
Last updated
2023-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Telerehabilitation

Keywords

COVID-19, Telerehabilitation, Exercise program, Breathing exercises

Brief summary

Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.

Detailed description

Fifty seven participants will be enrolled. Participants will be randomly divided into 3 groups. For this purpose, patients will be recruited at the time of discharge from the hospital and two experimental groups with the same physical therapy and educational program will be carried out. participants in the control group will only educational program. Participants in experimental groups will be followed using videoconference interviews from synchronous telerehabilitation methods and mobile application from asynchronous telerehabilitation methods at home. These participants will be given an 8-week exercise program. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and the patients will be evaluated before and after the treatment. After treatment programs, the functional capacity, performance, and hemodynamic parameters of the participants will be evaluated. Quality of life, physical activity level, anxiety-depression, and fatigue severity will also be evaluated with questionnaires.

Interventions

OTHERSynchronous telerehabilitation programme

Exercise program and educational program

Exercise program educational program

Sponsors

Marmara University
CollaboratorOTHER
Bitlis Eren University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Study

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* COVID-19 patients in the subacute period discharged * Be 18 years or older * Having received oxygen therapy or mechanical ventilation support in the hospital * Access to online interviews and web-based exercises with a secure internet connection * Having sufficient speaking and hearing skills for telerehabilitation * Volunteer to participate in research

Exclusion criteria

* Unstable clinical condition * Having had cerebrovascular disease, intra-articular drug injection or surgery of the lower extremities in the last 6 months * Inability to walk independently, even with an assistive device * Having serious neuromuscular problems * Not being cooperative enough to answer and understand questionnaires and scales

Design outcomes

Primary

MeasureTime frameDescription
Incremental Shuttle Walk Test (ISWT)Change from baseline walking distance (meters) of the patients at the end of the 8th week and, postintervation sixth monthsThe participant will be asked to walk around two 9-meter cones and complete them within the given time. Oxygen saturation and heart rate will be measured before and immediately after the test. They will be asked to self-report dyspnea and fatigue according to the modified Borg scale (0-10).

Secondary

MeasureTime frameDescription
30-Second Chair Stand Test (30 CST)Change from baseline number of sitting and staying of the patients at the end of the 8th week and, postintervation sixth monthsThe patient will be asked to sit and stand as much as possible within 30 seconds, with his hands crossed over his chest. The number of sitting and staying for 30 seconds will be noted.
Brief Physical Performance Battery (BPPB)Change from baseline score of the patients at the end of the 8th week and, postintervation sixth monthsIt is a test used to evaluate the lower extremity function of patients. This battery represents the sum of 3 functional tests such as standing stance tests, 4 meters walking test and 5 times chair sit and stand (5STS). Each test is scored between 0 (not completing the test) and 4 (highest performance level)

Other

MeasureTime frameDescription
International Physical Activity Questionnaire Short Form (IPAQ)Change from baseline metabolic equivalent (MET)-minute/week of the patients at the end of the 8th week and, postintervation sixth monthsIt is a scale used to determine the level of physical activity in adults. The scale questions vigorous and moderate physical activity, walking time of at least 10 minutes and daily sitting time in the last 7 days.
Hospital Anxiety Depression (HAD) ScaleChange from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth monthsThe questionnaire, which was filled in by the patient and includes the anxiety and depression subscales, consists of 14 items. Responses are scored between 0-3.
Oxygen Saturation and Heart RateChange from baseline oxygen saturation (SaO2) and heart rate (beats per minute) of the patients at the end of the 8th week and, postintervation sixth monthsParticipants' resting oxygen saturation and heart rate, and oxygen saturation and heart rate after the tests will be evaluated
Quality of Life Scale: Short Form-36 (SF-36)Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth monthsThe self-assessment scale consists of 36 items and 8 sub-dimensions. The scale is evaluated considering the last four weeks. On the scale, 0 points indicate poor health and 100 points indicate good health.
Fatigue Severity ScaleChange from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth monthsThis scale is a 9-item scale that measures the severity of fatigue in patients and its effect on one's activities and lifestyle. Responses are scored on a seven-point scale with 1 = strongly disagree and 7 = strongly agree.
Dyspnea and Fatigue LevelChange from baseline dyspnea and fatigue of the patients at the end of the 8th week and, postintervation sixth monthsParticipants' dyspnea and fatigue level, and dyspnea and fatigue level after the tests will be evaluated according to the Modified Borg (0-10) scale
Timed Up-Go Test (TUG)Change from baseline time (second) of the patients at the end of the 8th week and, postintervation sixth monthsParticipants are asked to get up from the chair, walk 3 m at a comfortable and safe pace, return and sit back in the chair.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026